Still super cheap at these prices, even with all the negativity. They are still expecting greater than 10% earnings growth and that is being conservative
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025